Plus Therapeutics sets 2026 annual meeting for May 14; proxy deadlines March 22

PLUS THERAPEUTICS, INC.

Annual meeting scheduled for May 14, 2026 at 9:00 a.m. ET, held virtually.
Record date for stockholders is March 18, 2026.
Deadline for Rule 14a-8 stockholder proposals and director nominations: March 22, 2026.
Meeting date is more than 30 days before 2025 anniversary, rendering prior proxy deadlines void.
Universal proxy rule compliance notice also due by March 22, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.